GB:0GTN Stock Latest News
Company AnnouncementsBioGaia boosts margins and expands probiotic reach in Q3 20261w ago
Company AnnouncementsBioGaia names Nomination Committee for 2027 AGM2w ago
Company AnnouncementsBioGaia Sets October 22 Date for Q3 2026 Results and Investor Briefing3w ago
Company AnnouncementsBioGaia to Outline Long-Term Strategy at London Capital Markets Day1M ago
Company AnnouncementsBioGaia launches clinically proven colon health probiotic Colus1M ago
Company AnnouncementsBioGaia Deepens Iberian Partnership With Recordati to Drive Probiotic Growth2M ago- Company AnnouncementsBioGaia Sets July 17 Date for Q2 2026 Earnings and Investor Audiocast4M ago
- Company AnnouncementsBioGaia Expands Microbiome Skincare Line for Babies and Children4M ago
- Pre-Earnings0GTN Upcoming Earnings Report: What to Expect?5M ago
- Company AnnouncementsBioGaia AGM Confirms Dividend, Charitable Grants and New Incentive Plan5M ago
Company AnnouncementsBioGaia Posts Solid Q1 Growth, Tightens U.S. Grip and Bolsters Probiotic Science5M ago
Company AnnouncementsBioGaia launches next-generation dual-strain probiotic drops for colicky infants5M ago
- Company AnnouncementsBioGaia research validates LongevityGuard technology in boosting probiotic shelf life6M ago
Company AnnouncementsBioGaia Sets May 7 AGM to Vote on Board Slate and New Performance Share Plan7M ago
Company AnnouncementsBioGaia Publishes 2025 Annual and Sustainability Report7M ago
Company AnnouncementsBioGaia study links infant probiotic use to sharply lower childhood abdominal pain7M ago
Company AnnouncementsBioGaia’s Infant Colic Trial Completion: What Investors Should Watch Next7M ago0GTN
